NCT00962442View on ClinicalTrials.gov

N-Acetylcysteine in Severe Acute Alcoholic Hepatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

January 31, 2006

Conditions
Alcoholic Hepatitis
Interventions
DRUG

N-Acetylcysteine

300 mg/kg for 14 days, intravenously

DRUG

placebo

Glucosé 5% perfusion for 14 days, intravenously

Trial Locations (1)

1070

Erasme University Hospital, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT00962442 - N-Acetylcysteine in Severe Acute Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter